Table 1.
Baseline characteristics.
| Pharm-TCR | TAU | |
|---|---|---|
| Sex | ||
| Male (%) | 44 | 43 |
| Female (%) | 56 | 57 |
| Age (years) | 58 (11) | 59 (8) |
| T2D Duration (years) | 11.8 (8.0) | 8.8 (8.0) |
| Body weight (kg) | 102.3 (21.6) | 103.4 (19.7) |
| BMI (kg/m2) | 36.0 (6.0) | 35.1 (5.3) |
| Waist Circumference (cm) | 115.6 (13.6) | 115.8 (16.3) |
| Body Fat % (%; percentage points) | 39.0 (6.3) | 40.2 (6.3) |
| Systolic Blood Pressure (mmHg) | 138 (17) | 136 (16) |
| Diastolic Blood Pressure (mmHg) | 80 (14) | 82 (13) |
| HbA1c (%; percentage points) | 7.9 (1.5) | 7.8 (1.4) |
| HbA1c (mmol/mol) | 63 (16) | 61 (15) |
| Fasting Glucose (mmol/L) | 9.3 (3.2) | 9.3 (3.1) |
| GGT (U/L) | 40.8 (39.6) | 47.8 (42.6) |
| AST (U/L) | 24.1 (13.9) | 31.1 (21.5) |
| ALT (U/L) | 31.3 (20.0) | 42.8 (30.5) |
| HDL Cholesterol (mmol/L) | 1.21 (0.32) | 1.21 (0.31) |
| LDL Cholesterol (mmol/L) | 2.38 (0.95) | 2.49 (0.98) |
| Total Cholesterol (mmol/L) | 4.46 (1.15) | 4.56 (1.13) |
| Triglycerides (mmol/L) | 1.97 (1.47) | 2.0 (1.02) |
| hs-CRP (mg/L) | 5.1 (5.3) | 5.5 (5.1) |
| Medication Effect Score | 2.1 (1.7) | 1.8 (1.7) |
| Leisure Score Index | 22.2 (26.7) | 23.7 (21.7) |
| Health Related Quality of Life | ||
| Physical Functioning | 70.1 (28.8) | 69.6 (28.2) |
| Role Functioning | 71.9 (39.1) | 71.7 (40.7) |
| Social Functioning | 81.3 (27.9) | 84.4 (25.4) |
| Mental Health | 76.7 (16.6) | 74.4 (16.3) |
| Health Perceptions | 52.8 (24.4) | 49.2 (23.6) |
| Pain | 41.6 (27.0) | 47.6 (21.3) |
Data are mean (SD). T2D Type 2 diabetes, BMI Body mass index, GGT Gamma-glutamyl transferase, AST Aspartate aminotransferase, ALT Alanine aminotransferase, HDL High-density lipoprotein, LDL Low-density lipoprotein, hs-CRP high-sensitivity C-reactive protein